Introduction
Antibodies have become indispensable tools as research reagents [1] , in diagnostics [2] and as therapeutics [3 5] . To avoid immunisation of animals and to better tune the molecular characteristics of antibody reagents in vitro, several library-based methods mimicking natural evolution for screening and identification of antibody-antigen interactions have been developed [6] . Phage display [7, 8] is currently the most widely used selection platform, its success mainly owing to its ability to conveniently harbour large libraries together with ease of handling. Other display formats include ribosome display [9, 10] and cell based display platforms such as E. coli [11] , yeast [12] and mammalian display [13] . The use of cell-based platforms offers several advantages compared to the capture and elution procedure of phage and ribosome display. Since cells, as opposed to phage, are large enough to be detected by light scatter in a flow cytometer, cells displaying a library of antibodies can be incubated with a fluorescently labeled antigen, allowing simultaneous real-time screening and selection. As the stringency of the sorting can easily be manipulated by changing the fluorescence gate, the discriminatory capacity and control of the system is superior [14] . In addition, the multivalent copies of affinity proteins displayed on the cells enable quantitative screening of relative affinities and selected clones can subsequently be characterised individually by flow cytometry without the need for sub-cloning.
Currently, several cell-based display systems are available. Yeast cells, being eukaryotic, possess glycosylation, disulphide-bridge forming and protein folding machineries similar to those of human cells. Differences, however, do exist between yeast and human processing [15] and glycosylation is typically not desirable during selection of scFv clones, as they will ultimately be reformatted and expressed as fulllength antibodies in mammalian cell lines. Several display scaffolds derived from Gram-negative bacteria have also been employed in surface display [16, 17] , where E. coli is often the most commonly used host and its application in isolation of antibodies from libraries has been reported [18] . Recognising the capabilities of yeast and E. coli as display platforms, we believe it would also be interesting to utilise Gram-positive bacteria in the selection of antibody fragments from recombinant libraries. In contrast with Gram-negatives, the outer layer of Gram-positive bacteria comprises only a single (plasma) membrane and one layer of peptidoglycan, making the translocation of anchored fusion proteins straightforward. The thicker peptidoglycan layer also acts as a physical barrier, protecting the cells from the harsh environment in the flow cytometer, leading to increased cell viability after sorting, a key requirement of cell surface display. Another key difference between Gramnegative and Gram-positive bacteria is the difficulty of transformation of the latter, which until lately [19] has made work in Gram-positive hosts difficult. Previous work has shown the potential of the Gram-positive Staphylococcus carnosus to be used in the selection of affinity proteins and enzymes of bacterial origin [20, 21] , cysteine-free camelid single domain antibodies [22] , and for epitope mapping of linear [23] and structural epitopes [24] . S. carnosus surface display of a single murine scFv [25] , as well as an attempt to express a library of several human multi-domain proteins and fragments [26] , has further demonstrated the potential for this platform to display folded, functional, complex human proteins.
Building on previous experience of S. carnosus as a robust host for surface display and flow sorting, here we have further challenged it by using it as a platform for selection of human antibody fragments. The aim of this proof-of-principle study was to show the viability of this platform for selection and isolation of high affinity binders from antibody libraries. We demonstrate the first Gram-positive surface display of a human antibody library, by subcloning into S. carnosus a synthetic human scFv library pre-selected by phage display. We further show the combination of the two display methods by isolation of scFv with low nanomolar affinity against human epidermal growth factor receptor 2 (HER2) and demonstrate the usefulness of the Gram-positive platform as an efficient method for affinity maturation. We propose Gram-positive display as a convenient alternative for screening of moderately sized antibody libraries, such as those pre-enriched by phage display or affinity maturation libraries. We suggest that the combination of phage and Gram-positive bacterial display has the potential for a more complete scanning of the antibody repertoire than numerous individual ELISA screenings.
Materials and Methods

Phage display selections and characterisation of anti-HER2 scFv
Phage from HelL-11, a human synthetic scFv library [27] , were cycled through rounds of selections with the extracellular domain of HER2 (Sino Biological, Beijing, PR China) as capture target. The antigen was covalently linked to magnetic beads with carboxylic instructions (Dynabeads; Life Technologies, Carlsbad, CA, USA). Phage displaying nonspecific scFv were removed in a pre-selection step by incubating the library diluted in TPBSB (0.05% Tween 20 and 1% BSA in PBS) with the same type of bead but containing no antigen for 1h at room temperature (RT) and slow rotation.
Subsequently the supernatant was transferred to the HER2-coated beads and similarly incubated for 1.5h. Following 4-7 rounds of washing in TPBS (0.05% Tween 20 in PBS) using a KingFisher Flex instrument (Thermo Scientific), the bound phages were eluted with trypsin, which cleaves at a trypsin-site located between the displayed scFv and protein III. The enzymatic activity was inhibited by the addition of aprotinin. Eluted phages were propagated by infection of E. coli XL1-Blue (Stratagene, La Jolla, CA, USA), infected with M13K07 (New England Biolabs, Beverly, MA, USA) for phage production and amplified in solution overnight at 30 °C. Harvested phage stocks were precipitated with polyethylene glycol (PEG), resuspended in PBS containing 0.1% BSA and used for subsequent rounds of selection. In total, three rounds of selections were carried out on gradually decreasing amounts of antigen and increasing number of washes.
Phagemid DNA from the third round of selection was isolated and recloned to allow production and analysis of soluble scFv. The DNA was digested with the restriction enzymes SfiI and AvrII (New England Biolabs, Ipswich, MA, USA) and ligated into the pHP2-15 vector [27] that provides the secreted scFv with three FLAG-epitopes and a hexahistidine tag at their C-termini. The constructs were transformed into Top10 E. coli (Thermo Fisher Scientific, Waltham, MA, USA). Single colonies were picked and soluble scFv produced in 96-well plates containing media supplemented with isopropyl thiogalactoside (IPTG) by incubation overnight at 37 °C and vigorous shaking (800 rpm). After sedimentation of the bacteria, the supernatants containing the scFv were screened by enzyme linked immunosorbent assay (ELISA) for specific Her2 binding, using an HRP-labeled (horseradish peroxidase -labeled) anti-FLAG monoclonal antibody (Sigma Aldrich, St. Louis, MO, USA) as secondary conjugate.
Clones that bound to HER2 but not BSA were subjected to DNA sequencing.
Cloning of human scFv and library into S. carnosus All scFv constructs, i.e. individual clones as well as pre-enriched phage library pools, were sub-cloned into the Staphylococcal display vector pSCEM2 containing restriction sites NotI and AscI [26] . The scFv genes were amplified with PCR using primers containing NotI and AscI site handles and digested with respective restriction ructions (Thermo Fisher Scientific). The genes were ligated into pSCEM2 and transformed into E. coli s. The single genes were prepared with QIAprep kit (Qiagen) and the gene library was prepared with a JETSTAR kit (Genomed, Bad Oeynhausen, Germany) according to the manufacturer's recommendations and transformed into electrocompetent S.
carnosus TM300 using a previously described protocol [19] . The displayed scFv cassette on S. carnosus consisted of pro-peptide (PP) and signal peptide (S) at the Nterminal, followed by the scFv with an albumin binding protein (ABP) and a XM domain for cell wall anchoring at the C-terminal.
Error Prone PCR mutagenesis
Error prone mutagenesis of wild type clone SC1 was performed using GeneMorph II Random Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA) in used as the template and subjected to 25 cycles of PCR. The resulting library product was cloned into the vector pSCEM2 and transformed as described above. 
Production of scFv binders as soluble molecules in E. coli
Chosen clones were amplified with PCR containing SfiI and AvrII restriction sites and digested with the corresponding enzymes, cloned into the pHP2-15 vector and transformed into TOP10 E. coli cells for expression of soluble molecules. Colonies were inoculated in Terrific Broth medium containing isopropyl thiogalactoside (IPTG) and soluble scFv produced overnight at 30ºC. The proteins were purified from the periplasmic fraction making use of the hexahistidine tag and -NTA magnetic beads (Thermo Fisher) following the Sample elution was performed in PBS containing 500 mM imidazole at pH8. The eluted scFvs were desalted using dialysis against PBS.
Analysis of scFv molecules on Octet RED96
To confirm successful selection and affinity maturation, the affinities of the two matured scFvs towards HER2 extracellular domain (ECD) in comparison with the non-matured scFvs were measured by biolayer interferometry (BLI) on an Octet 
Results
As illustrated in Figure 1 , we present a work scheme for display, selection and screening of human scFv libraries using S. carnosus display coupled to flow cytometric sorting, after initial enrichment by phage display. The scFv displayed on S.
carnosus is preceded by a pro-peptide (PP) and signal peptide (S) at the N-terminal and has an albumin binding protein (ABP) and a XM domain for cell wall anchoring at the C-terminal ( Figure 1A-B ). During the selection process ( Figure 1C ), target- Fluorescence detection and enrichment of cells expressing scFv on the surface of S. carnosus from a mock library.
Herceptin (Trastuzumab) in its full-length antibody form binds with high affinity to
HER2. We cloned Herceptin as an scFv with a translocation signal for expression and anchoring to the surface of S. carnosus [30] under the control of a constitutive promoter ( Figure 1 ). Transformed cells were detected in the flow cytometer by the size and granularity parameters, forward (FS) and side scatter (SS) (Figure 2A ).
HER2 binding was detected with biotinylated HER2 and streptavidin-rPE (FL2)
whereas surface expression was detected with HSA 647 (FL6). We observed a clear surface expression signal at 40 nM HSA Alexa 647 for both Herceptin scFv (73% of cells within FL6 gate) and an anti-CTLA4 scFv (63% of cells within FL6 gate) ( Figure 2B-C) .
In the next step, we generated a mock library with Herceptin scFv clones spiked into a background of anti-CTLA4 scFv clones at a ratio of 1:10,000. The purpose of this experiment was to verify that the platform could be used to enrich positive binders against a target protein from negative binders in a library size similar to that typically obtained after initial pre-enrichment of a naïve library by phage. Flow cytometric cell sortings yielded enrichment after each round, and after two rounds of selection the ratio of Herceptin scFv to CTLA-4 scFv was 1:15 clones ( Figure 2D-F) . This shows the possibility of using FACS to enrich human scFv in Gram-positive display libraries.
Isolation of binders from pre-enriched antibody libraries using Gram-positive display
To further challenge the system, we used S. carnosus as a platform for library selection of novel antibody fragments specific for HER2. Prior to bacterial surface display, three rounds of phage selections on HER2 were performed using a human synthetic scFv library (Hell-11) of >10 10 members complexity [27] . of the population was sorted ( Figure 3A, middle) . A clear enrichment could be seen following these two rounds of cytometric sorting ( Figure 3A, right) .
Characterisation of individual selected clones
We picked 96 positive single clones after two rounds of library sorting for on-cell flow cytometry analysis. The clones were ranked based on mean fluorescence intensity of antigen binding (FL2) while also taking surface expression (FL6) into consideration and 96 clones were sequenced of which 18 sequences were unique. The three best clones (SC1, SC39 and SC66) were chosen for a more detailed analysis.
This involved flow cytometry analysis using scFv in surface displayed form ( Figure   3B ), as well as affinity determination by BLI using purified soluble scFv molecules ( Table 1 ) and live cell HER2 binding using scFv reformatted as full length monoclonal antibodies ( Figure 3C) .
Clonal on-cell flow cytometry analysis of the binders confirmed binding to native HER2 for all binders, with a slightly varying binding characteristics for each clone ( Figure 3B ). Cells were incubated with the same concentration of labeled HER2, followed by measurement of FL2 median antigen binding signal ( Figure 3B right) in the gate containing surface expressed clones (Figure 3B left) . The data shows that Herceptin in scFv-displayed form had the highest amount of bound HER2, as evidenced by the highest fluorescence signals. Taking only the antigen binding signal (FL2) into account, SC1 had the highest antigen binding of the three isolated clones followed by SC66 and SC39. This ranking remains when normalizing the antigen binding signal (FL2) to the surface expression signal (FL6) ( Table 1 , Supplementary   Figure S1 ), but the stronger binding of SC66 compared to SC39 becomes more pronounced. As expected, the negative control CTLA-4 showed no binding.
Affinity measurements with scFvs produced as soluble proteins were performed using BLI ( Table 1 , Supplementary Figure S2 Figure 3B ) and surface expression normalised antigen binding ( Table 1 , Supplementary Figure S1 ).
Taken together these experiments suggest that Gram-positive display enables the isolation of high-affinity binders from a human antibody library.
Characterisation of selected clones reformatted as full length human monoclonal antibodies
Since functional full-length monoclonal antibodies are often desired for therapeutic purposes, the selected binders (SC1, SC39, SC66) were cloned as full length antibodies. Cloning of the scFvs into human constant region frameworks for both heavy and light chains was performed using automated robot cloning [28] . The constructs were used to transfect HEK293T cells and a Western blot analysis was conducted to confirm that the monoclonal antibodies were produced in comparable amounts ( Figure 3C, left) . The antibody-containing medium supernatants were then used to assess binding on live SKOV3 cells using flow cytometry (Figure 3C, right) .
The antibody levels in each sample supernatant was first determined using ELISA and the different sample supernatants then adjusted for slight variations in antibody concentrations before incubation with SKOV3 cells and measurement of median fluorescence by flow cytometry. As expected, the full-length forms of Herceptin, SC1, SC66 and SC39 were all positive in SKOV3 binding with Herceptin having the highest signals. Furthermore, we observed the same relative ranking of binding strength between the samples when compared to the two previous assays (ranking on S. carnosus and using BLI). We could therefore conclude that the binding characteristics obtained from the clones in scFv format on S. carnosus are retained when reformatted into full-length antibodies.
Affinity maturation of wild type SC1 and isolation of mutants with enhanced affinities One of the selected binders (SC1) was subjected to affinity maturation using error prone PCR. The resulting 10 4 library with an average of two mutated amino acids per gene, was sorted by flow-cytometry in a similar manner as the phage pre-enriched library ( Figure 4A ). Two isolated binders from the affinity maturation library (SC1M2, SC1M4) were again selected for detailed analysis. Clonal characterisation using both on cell flow cytometry analysis using scFv in surface anchored form ( Figure 4B ) as well as affinity characterisation using BLI of soluble scFv molecules ( Table 1 , Supplementary Fig. S2 ) showed improved binding for both affinity maturated mutants, of which SC1M4 showed the largest improvement of affinity. The association and dissociation constants (Table 1 ) and the sensorgrams (Supplementary Figure S2 ) illustrate that this improvement was due to both a higher on-and a slower off-rate. Although SC1M2 appears very close to SC1 in the flow cytometry analysis ( Figure 4B) , when looking at the antigen binding signal (FL2) only, the improvement in affinity is clearer visualised when accounting for surface expression (Table 1 , Supplementary Figure S3 ). This highlights the utility of the simultaneous monitoring of binding and surface expression for the ranking of clones. Both the stronger binder SC1M4, with mutations in three positions, as well as SC1M2, with one mutation, had mutations located outside the CDRs (Supplementary Figure S4) .
Despite the modest improvement in affinity, we are able to demonstrate the possibility of using S. carnosus for affinity maturation of human scFv without the need for phage display.
Discussion
In this paper we present the first use of Gram-positive bacteria for display of human antibody libraries. We have shown that Gram-positive bacterial display can be used to isolate human scFvs with low nanomolar dissociation constants from a human antibody library pre-enriched by phage display. By combining bacterial display with phage display, we were able to use the advantages of both platforms. While phage display enables generation of larger libraries than bacterial display, the latter allows for thorough and fast screening and enrichment of binders using flow cytometry sorting, the equivalent of thousands of individual ELISA screening assays of E. coli expressed scFv proteins [34] . Furthermore, flow cytometric sorting enables the possibility of monitoring the binding process in real-time and gating a binding population for sorting of clones for subsequent rounds of selection and or downstream characterisation. A more stringent definition of the desired gate can be used to further minimise the sorting of non-binding clones. We have chosen to monitor fluorescent signal for both binding and surface display to allow sorting of clones based on their apparent affinity rather than their abundance on the cell surface. In the case of the three top binders identified by FACS here, none was present in an initial ELISA screening (47 clones) of the phage pre-selected library and only two (SC1 and SC66)
were found after a more thorough ELISA screening (approx. 300 clones), whereas the third (SC39) could not be found. This was likely due to it being present in a much lower abundance and therefore requiring more time and effort to be successfully found by microtiter plate ELISA. Since the combination of phage display and deep sequencing allows for the time-and labour-efficient identification of rare binders [35, 36] , we believe it would also be interesting to combine phage display and deep sequencing with this screening platform to validate the functional binding of such a variety of clones.
By characterising the selected binders, we have also found that the relative binding ranking of the scFv displayed on S. carnosus is in line with the ranking of KD values determined by BLI as well as ranking of binding to native HER2 present on SKOV3 cells using scFv reformatted as full length antibodies. Another potential benefit of selecting binders through a series of orthogonal selection systems could be the isolation of robust proteins with better general folding behaviour. This would be a desirable trait both as scFv or expressed as full-length proteins in a mammalian production host, as conversion of a phage display selected scFv into full length IgG may lead to a decrease in affinity [37] . In addition, switching expression system and affinity gating normalised on expression level could circumvent potential amplification or toxic biases that are sometimes observed in phage display systems [38] .
As a final step, the staphylococcal display system was used successfully to affinity mature one of the earlier selected binders to show that this platform provides an efficient and streamlined approach to yield high-affinity binders. Although the mutations of both affinity matured clones were located outside the CDR-regions, we speculate that future usage of S. carnosus scFv libraries with diversity introduced in the CDRs using synthetic oligonucleotides is a viable alternative to error-prone PCR based libraries, with the potential to give an even better improvement in affinity.
In summary, we believe the technology we have developed here by combining phage display with staphylococcal display allows for a rapid and efficient generation of robust, high-affinity binders and aids the identification of low abundance library variants. Previous applications of this display platform together with observations noted in this study indicate that S. carnosus display can be utilised to complement existing technologies, particularly in combination with phage display. This is also the first time that human antibody fragments (scFv) have been subjected to library selection on Gram-positive bacteria. It would thus be interesting to perform selections against several other targets and compare the results with other platforms on a larger scale by utilising massively parallel sequencing methods [39 41 ]. 
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